2016
DOI: 10.1136/heartjnl-2015-308712
|View full text |Cite
|
Sign up to set email alerts
|

Early β-blocker use and in-hospital mortality in patients with Takotsubo cardiomyopathy

Abstract: This study found no significant association between early β-blocker use and in-hospital mortality in patients with TC.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
85
0
3

Year Published

2016
2016
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 111 publications
(89 citation statements)
references
References 32 publications
1
85
0
3
Order By: Relevance
“…Equally there is no medication that is able to prevent recurrences or to mitigate the symptoms that a proportion of these patients continue to experience34 after they recover from their acute illness. Retrospective registry data suggest that beta-blockers are not useful in preventing acute in-hospital mortality43 or recurrences. However, randomised clinical trials with prespecified end-points in takotsubo have not taken place and remain premature until a more clear mechanism of disease is elucidated in humans.…”
Section: The Aftermath Of a Takotsubo Episodementioning
confidence: 99%
“…Equally there is no medication that is able to prevent recurrences or to mitigate the symptoms that a proportion of these patients continue to experience34 after they recover from their acute illness. Retrospective registry data suggest that beta-blockers are not useful in preventing acute in-hospital mortality43 or recurrences. However, randomised clinical trials with prespecified end-points in takotsubo have not taken place and remain premature until a more clear mechanism of disease is elucidated in humans.…”
Section: The Aftermath Of a Takotsubo Episodementioning
confidence: 99%
“…53 Many advocate anticoagulation in cases where LV thrombi are detected or support anticoagulation in all patients until the akinetic wall motion abnormalities have resolved. 26 A repeat echocardiography is advisable before hospital discharge as well as follow-up one to six months afterward.…”
Section: Managementmentioning
confidence: 99%
“…In addition, cardiogenic shock patients had higher incidence of significant mitral regurgitation and LVEDP, likely as a consequence of the underlying systolic dysfunction and LVOTO (5) The role of early β-blocker in TCM has been controversial. Their use in cardiogenic shock associated with LVOTO has been suggested to allow better diastolic relaxation, better forward flow and improvement in systolic pressure (2,27,28), conversely, their role in improving short term mortality has been questioned recently (29). Similarly, the use of β-blockers to prevent recurrence has not been proven beyond doubt (2,25,30,31).…”
Section: Discussionmentioning
confidence: 99%